Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function via Modulating the Mammalian Target of Rapamycin Pathway-Reference-Cited by-同舟云学术

Dihydroartemisinin Ameliorates Inflammatory Disease by Its Reciprocal Effects on Th and Regulatory T Cell Function via Modulating the Mammalian Target of Rapamycin Pathway

Published:2012-09-19 Issue:9 Volume:189 Page:4417-4425
ISSN:0022-1767
Container-title:The Journal of Immunology
language:en
Short-container-title:J.I.

Author:

Zhao Yan G.,Wang Yunqi,Guo Zengli,Gu Ai-di,Dan Han C.,Baldwin Albert S.,Hao Weidong,Wan Yisong Y.

Publisher

The American Association of Immunologists

Subject

Immunology,Immunology and Allergy

Reference43 articles.

1. Qinghaosu (Artemisinin): an Antimalarial Drug from China

2. Antimalarial combinations

3. Artemisinins target the SERCA of Plasmodium falciparum

4. Selective toxicity of dihydroartemisinin and holotransferrin toward human breast cancer cells

5. Antimalarial dihydroartemisinin also inhibits angiogenesis

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dihydroartemisinin inhibits follicular helper T and B cells: implications for systemic lupus erythematosus treatment;Archives of Pharmacal Research;2024-07

2. Artemisinin and its derivatives as promising therapies for autoimmune diseases;Heliyon;2024-04

3. Adjuvant Anti-tumor Therapy with Polyphenolic Compounds: A Review;Current Medicinal Chemistry;2024-03-06

4. Artemisinins: Promising drug candidates for the treatment of autoimmune diseases;Medicinal Research Reviews;2023-12-06

5. Dihydroartemisinin ameliorates innate inflammatory response induced by Streptococcus suis-derived muramidase-released protein via inactivation of TLR4-dependent NF-κB signaling;Journal of Pharmaceutical Analysis;2023-10